Deciduoid Variant

The deciduoid variant is a rare and aggressive subtype of epithelioid mesothelioma in which tumor cells resemble the large, plump cells of the decidua, the lining of a pregnant uterus. Its unusual appearance can lead to misdiagnosis on biopsy, so expert pathology review with immunohistochemical staining is often needed. It can occur in the pleura or peritoneum and generally carries a worse prognosis than typical epithelioid mesothelioma.

Origin

The term comes from the Latin deciduus ("falling off"), the same root used for the decidua of the pregnant uterus, whose cells the tumor resembles. The deciduoid pattern was first described in peritoneal mesothelioma in young women in the 1990s (Nascimento and colleagues, 1994), and was later recognized in the pleura and in men as well.

Significance in Asbestos Context

For patients, the deciduoid variant matters in three concrete ways. First, it is easily mistaken on biopsy for other conditions, including reactive mesothelial proliferation, carcinoma, or even decidual tissue in women, so an accurate diagnosis often requires expert pathology review and immunohistochemical staining (calretinin, WT-1, D2-40, cytokeratin). Second, it tends to behave more aggressively than ordinary epithelioid mesothelioma, which affects treatment decisions, eligibility for surgery, and prognosis discussions. Third, because it is still a form of mesothelioma, it carries the same well-established causal link to asbestos exposure, and the legal standards for asbestos-related mesothelioma claims apply, but defendants sometimes try to exploit the unusual histology to argue diagnostic uncertainty, so a clearly worded pathology report is important.

Example Sentence

After the initial biopsy was read as "atypical cells of uncertain origin," a second opinion at a mesothelioma referral center identified the tumor as the deciduoid variant of epithelioid mesothelioma.

Related Terms

Epithelioid Mesothelioma, Mesothelioma Histologic Subtypes, Immunohistochemistry, Peritoneal Mesothelioma, Pathology Second Opinion

Notes

• Request that biopsy slides be reviewed by a pathologist experienced in mesothelioma; misdiagnosis is well-documented with this variant and can delay correct treatment.
• Ask whether immunohistochemical markers (calretinin, WT-1, D2-40, cytokeratin 5/6) and carcinoma markers were performed to confirm mesothelial origin and rule out metastatic carcinoma.
• Preserve all pathology reports, slide numbers, and the original biopsy blocks. These are often re-examined for clinical trials, second opinions, and legal claims.
• Because deciduoid mesothelioma is rare and aggressive, ask your oncologist about referral to a high-volume mesothelioma center and about eligibility for clinical trials.
• Make sure your occupational and household asbestos exposure history is documented in the medical record early; this supports both diagnosis and any future legal claim.